CathVision helps guide ablation therapy of cardiac arrhythmia with novel hardware, software and data science.
CathVision has raised $9.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2023.
CathVision's investors include Vaekstfonden, Innovation Fund Denmark, Horizon 2020, Nordic Secondary Fund, Borean Innovation.
CathVision is headquartered in Copenhagen, Denmark.
CathVision helps guide ablation therapy of cardiac arrhythmia with novel hardware, software and data science.
CathVision is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CathVision — Funding & Investors." VCBacked, July 18, 2023, https://www.vcbacked.co/company/cathvision. Accessed October 19, 2026.
VCBacked. (2023). CathVision — Funding & Investors. Retrieved October 19, 2026, from https://www.vcbacked.co/company/cathvision
{{cite web |title=CathVision — Funding & Investors |url=https://www.vcbacked.co/company/cathvision |website=VCBacked |access-date=October 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated